The medical use of Wheatgrass: review of the gap between basic and clinical applications.

2015 Jan 1
01/01/2015
By Bar-Sela G, Cohen M, Ben-Arye E, Epelbaum R.

A wide range of health benefits have been attributed to wheatgrass, the young grass of the common wheat plant Triticum aestivum. Its components include chlorophyll, flavonoids, and vitamins C and E. Forms of wheatgrass include fresh juice, frozen juice, tablets, and powders, with compositions varying according to their production processes, as well as to the growing conditions of the wheatgrass. Laboratory in vitro studies, mostly using the fermented wheat germ extract, have demonstrated anti-cancer potential and have identified apoptosis as a possible mechanism. In animal experiments, wheatgrass demonstrated benefits in cancer prevention and as an adjunct to cancer treatment, as well as benefits to immunological activity and oxidative stress. Clinical trials show that wheatgrass may induce synergistic benefits to chemotherapy and may attenuate chemotherapy-related side effects, as well as benefit rheumatoid arthritis, ulcerative colitis, hematological diseases, diabetes, obesity, and oxidative stress. However, all the trials were small and a number of methodological problems arose. No adverse events of wheatgrass have been reported, although some forms pose problems of tolerability. The popularity of wheatgrass continues to grow. Nevertheless, the advantages seen in the clinical trials need to be proved in larger studies before clinical recommendations for the public can be given.

More publications on the subject

Feasibility study of a systematic approach for discontinuation of multiple medications in older adults: addressing polypharmacy
Background: Polypharmacy and inappropriate medication use is a problem in elderly patients, who are more likely to experience adverse effects from multiple treatments and less
The oncologist’s role in delivering palliative care
Abstract Given that such a substantial proportion of oncology patients have advanced and/or incurable cancer oncologists invariably face enormous challenges in maintaining or improving
The cultural context of patient’s autonomy and doctor’s duty: passive euthanasia and advance directives in Germany and Israel
01/11/2010
Abstract The moral discourse surrounding end-of-life (EoL) decisions is highly complex, and a comparison of Germany and Israel can highlight the impact of cultural
Selected issues in palliative care among East Jerusalem Arab residents
01/01/2010
Abstract Understanding of cultural context is important when working with Palestinian patients, particularly in Israeli hospitals. Cultural competence includes individual assessment of communication needs
End-of-life needs as perceived by terminally ill older adult patients, family and staff
01/09/2010
Abstract Purpose of the study: A comparison of inpatient end-of-life needs as perceived by terminally ill older adult patients, family, physicians and nurses, is lacking.
The cultural context of end-of-life ethics: a comparison of Germany and Israel
01/07/2010
No abstract available